Drug information–seeking intention and behavior after exposure to direct-to-consumer advertisement of prescription drugs

Yuan United States General Accounting Office. FDA oversight of direct-to-consumer advertising has limitations. Report to congressional requesters. Report no. GAO-03-177. October 2000. Miller, 1999, Are current DTC ads ineffective?, Med Mark Media, 34, 38 Weissman, 2003, Consumers' reports on the health effects of direct-to-consumer drug advertising, Health Aff, W3-82, 10.1377/hlthaff.W3.82 Melillo, 1999, FDA cites most DTC drug spots, Adweek, 40, 4 2003, Free rein for drug ads? A slowdown in FDA review has left consumers more vulnerable to misleading messages, Consum Rep, 68, 33 Moncavage M. US FDA, Division of Drug Marketing, Advertising and Communications. DTC prescription drug promotion update from FDA. Presented at DTC National 2003. Boston, Mass. March, 2003. <www.fda.gov/cder/ddmac/presentations.htm>. Accessed 04.20.03. Aikin JK. US FDA, Division of Drug Marketing, Advertising and Communications. Direct-to-consumer advertising of prescription drugs: patient survey results. Presented at Healthcare Marketing Communications Council. September, 2002. <www.fda.gov/cder/ddmac/presentations.htm>. Accessed 01.20.03. Maddux, 1995, Self-efficacy and health behavior: prevention, promotion and detection, 19 Ajzen, 1988 Ajzen, 1991, The theory of planned behavior, Organ Behav Hum Decis Process, 50, 179, 10.1016/0749-5978(91)90020-T Roter, 1984, Patient question asking in physician-patient interaction, Health Psychol, 3, 395, 10.1037/0278-6133.3.5.395 Schommer, 1994, Pharmacists' perceptions of patients' needs for counseling, Am J Hosp Pharm, 51, 478 Bandura, 1977, Self-efficacy: toward a unifying theory of behavioral change, Psychol Rev, 84, 191, 10.1037/0033-295X.84.2.191 Bandura, 1982, Self-efficacy mechanism in human agency, Am Psychol, 37, 122, 10.1037/0003-066X.37.2.122 Bandura, 1986 Bandura, 1998, Health promotion from the perspective of social cognitive theory, Psychol Health, 13, 623, 10.1080/08870449808407422 Ajzen, 1986, Prediction of goal-directed behavior: attitudes, intentions, and perceived behavioral control, J Exp Soc Psychol, 22, 453, 10.1016/0022-1031(86)90045-4 Trafimow, 2002, Evidence that perceived behavioral control is a multidimensional construct: perceived control and perceived difficulty, Br J Soc Psychol, 41, 101, 10.1348/014466602165081 Azjen, 2002, Perceived behavioral control, self-efficacy, locus of control, and the theory of planned behavior, J Appl Soc Psychol, 32, 1 Armitage, 2001, Social cognitive determinants of blood donation, J Appl Soc Psychol, 31, 1431, 10.1111/j.1559-1816.2001.tb02681.x Armitage, 1999, Distinguishing perceptions of control from self-efficacy: predicting consumption of a low-fat diet using the theory of planned behavior, J Appl Soc Psychol, 29, 72, 10.1111/j.1559-1816.1999.tb01375.x Armitage, 1999, The theory of planned behaviour: assessment of predictive validity and “perceived control”, Br J Soc Psychol, 38, 35, 10.1348/014466699164022 Manstead, 1998, Distinguishing between perceived behavioral control and self-efficacy in the domain of academic intentions and behaviors, J Appl Soc Psychol, 28, 1375, 10.1111/j.1559-1816.1998.tb01682.x Povey, 2000, Application of the theory of planned behaviour to two dietary behaviours: roles of perceived control and self-efficacy, Br J Health Psychol, 5, 121, 10.1348/135910700168810 Terry, 1995, The theory of planned behaviour: the effects of perceived behavioural control and self-efficacy, Br J Soc Psychol, 34, 199, 10.1111/j.2044-8309.1995.tb01058.x Sparks, 1997, The dimensional structure of the perceived behavioral control construct, J Appl Soc Psychol, 27, 418, 10.1111/j.1559-1816.1997.tb00639.x Odeina, 1997, The pharmacist's implementation of pharmaceutical care (PIPC) model, Pharm Res, 14, 135, 10.1023/A:1012032223328 Farris, 1999, Between intention and behavior: an application of community pharmacists' assessment of pharmaceutical care, Soc Sci Med, 49, 55, 10.1016/S0277-9536(99)00078-7 Cheung SF, Chan DKS. The Role of Perceived Behavioral Control in Predicting Human Behavior: a Meta-analytic Review of Studies on the Theory of Planned Behavior. Chinese University of Hong Kong; 2000, unpublished manuscript. Conner, 1998, Extending the theory of planned behavior: a review and avenues for future research, J Appl Soc Psychol, 28, 1429, 10.1111/j.1559-1816.1998.tb01685.x Netemeyer, 1991, A comparison of two models for the prediction of volitional and goal-directed behaviors: a confirmatory analysis approach, Soc Psychol Q, 54, 87, 10.2307/2786928 Altman, 1991, The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip, Arthritis Rheum, 34, 505, 10.1002/art.1780340502 Altman, 1990, The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand, Arthritis Rheum, 33, 1601, 10.1002/art.1780331101 Felson, 2000, Osteoarthritis: new insights. Part 1: the disease and its risk factors, Ann Intern Med, 133, 635, 10.7326/0003-4819-133-8-200010170-00016 Levy, 1999, How large a sample do we need? Simple random sampling, 70 Dillman, 1999 Aikin JK, Swasy J. US FDA, Division of Drug Marketing, Advertising and Communications. Analysis of the effects of DTC advertising on patient information seeking behavior. Presented at Drug Information Association. July, 2001. <www.fda.gov/cder/ddmac/presentations.htm>. Accessed 01.20.03. Bellamy, 1988, Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or the knee, J Rheumatol, 15, 1833 Prevention Magazine and APhA. “Navigating the medical marketplace: how consumers choose,” a joint survey. Washington, DC. 1997. Doucette, 1998, Consumer preferences for drug information after direct-to-consumer advertising, Drug Inf J, 32, 1081, 10.1177/009286159803200428 Peat, 2001, Clinical assessment of the osteoarthritis patient, Best Pract Res Clin Rheumatol, 15, 527, 10.1053/berh.2001.0171 Sutton, 1998, Predicting and explaining intentions and behavior: how well are we doing?, J Appl Soc Psychol, 28, 1317, 10.1111/j.1559-1816.1998.tb01679.x Siebert, 1999, Friendship and social support: the importance of role identity to aging adults, Soc Work, 44, 522, 10.1093/sw/44.6.522 Peterson, 2003, Patient use of the internet for information in a lung cancer clinic, Chest, 123, 452, 10.1378/chest.123.2.452 Fishbein, 1975 Three out of four Americans have access to the Internet, according to Nielsen Netratings. New York, NY: Netratings Inc; 2004. Cotton, 2004, Characteristics of online and offline health information seekers and factors that discriminate between them, Soc Sci Med, 59, 1795, 10.1016/j.socscimed.2004.02.020 Bell, 1999, Direct-to-consumer prescription drug advertising and the public, J Gen Intern Med, 14, 651, 10.1046/j.1525-1497.1999.01049.x Foley, 2000 FDA. Warning letter to Merck & Co Inc NDA 21-042 MACMIS ID # 9456 Vioxx (rofecoxib) tablets. Rockville, Md: FDA; 2001. FDA. Letter to G.D. Searle & Co re NDA 20-998 Celebrex (celecoxib) capsules, NDA 19-908 Ambien (zolpidem tartrate) tablets MACMIS ID #8518. Department of Health & Human Services; 2000. FDA. Letter to G.D. Searle & Co re NDA 20-998 Celebrex (celecoxib) capsules MACMIS ID #9514. Department of Health & Human Services; 2000. Bombardier, 2000, VIGOR Study Group. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis, N Engl J Med, 343, 1520, 10.1056/NEJM200011233432103 Peck P. Merck issues worldwide recall of Vioxx®. New York, NY: United Press International; 2004. Pfizer pulling ads for Celebrex®. CNN news. New York, NY. December 20, 2004. <http://money.cnn.com/2004/12/20/news/celebrex/index.htm>. Accessed 12.21.04.